EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private
EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.
2 across the spectrum. Choose a side on the bar to jump to it.
National story. 2 articles from 2 sources. Updated 7d ago.
How each side is putting it
Left
1 sourceCenter
1 sourceEQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private
Right
0 sourcesNo Right coverage yet.
A blind spot on this side of the story.